| NDC Code | 0591-2132-01 |
|---|
| Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01) |
|---|
| Product NDC | 0591-2132 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Doxylamine Succinate And Pyridoxine Hydrochloride |
|---|
| Non-Proprietary Name | Doxylamine Succinate And Pyridoxine Hydrochloride |
|---|
| Dosage Form | TABLET, DELAYED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190621 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA205811 |
|---|
| Manufacturer | Actavis Pharma, Inc. |
|---|
| Substance Name | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE |
|---|
| Strength | 10; 10 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC] |
|---|